Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Tmem158em1/Cya
Common Name:
Tmem158-KO
Product ID:
S-KO-13903
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tmem158-KO
Strain ID
KOCMP-72309-Tmem158-B6J-VA
Gene Name
Tmem158
Product ID
S-KO-13903
Gene Alias
2310037P21Rik; Ris1
Background
C57BL/6JCya
NCBI ID
72309
Modification
Conventional knockout
Chromosome
9
Phenotype
MGI:1919559
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tmem158em1/Cya mice (Catalog S-KO-13903) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000068140
NCBI RefSeq
NM_001002267
Target Region
Exon 1
Size of Effective Region
~0.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
TMEM158, also known as RIS1, is a gene whose function has been increasingly studied in the context of various cancers. It has been implicated in promoting tumor progression through various signaling pathways such as STAT3, PI3K/AKT, and TGF-β [1-4, 6-8, 10]. Genetic models, especially loss-of-function models, can significantly contribute to understanding its role in tumorigenesis.

In gliomas, silencing TMEM158 inhibited cell proliferation, and in vivo results confirmed the inhibitory effect of its down-regulation on glioma growth, suggesting its oncogenic role through STAT3 activation [1]. In lung adenocarcinoma, knockdown of TMEM158 produced opposite effects to its overexpression, which promoted cell proliferation, cell cycle progression, migration, and invasion, via the PI3K/AKT pathway [2]. In triple-negative breast cancer, overexpressed TMEM158 participated in EMT by activating the TGF-β pathway, promoting tumor migration, invasion, and metastasis [3]. Similar oncogenic roles were seen in pancreatic, colorectal, ovarian, and anaplastic thyroid carcinomas [4, 6-8, 10]. In contrast, in prostate cancer, TMEM158 was down-regulated, negatively regulated by AR signaling, and associated with better survival outcomes [4].

In conclusion, TMEM158 generally acts as an oncogene in multiple cancers, promoting processes like cell proliferation, migration, invasion, and drug resistance through various signaling pathways. However, in prostate cancer, it seems to have an opposite role. The study of TMEM158 using gene knockout or conditional knockout models has been crucial in uncovering its role in different cancer types, providing potential therapeutic targets for cancer treatment.

References:

1. Li, Jiabo, Wang, Xuya, Chen, Lulu, Zhang, Chen, Yang, Xuejun. 2022. TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas. In Cancer gene therapy, 29, 1117-1129. doi:10.1038/s41417-021-00414-5. https://pubmed.ncbi.nlm.nih.gov/34992215/

2. Xu, Tao, Yin, Fang, Shi, Kaihu. 2024. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/AKT pathway via interaction with TWIST1. In Experimental cell research, 437, 114010. doi:10.1016/j.yexcr.2024.114010. https://pubmed.ncbi.nlm.nih.gov/38508329/

3. Tong, Jiaci, Li, Haoran, Hu, Ye, Zhao, ZuoWei, Li, Man. 2022. TMEM158 Regulates the Canonical and Non-Canonical Pathways of TGF-β to Mediate EMT in Triple-Negative Breast Cancer. In Journal of Cancer, 13, 2694-2704. doi:10.7150/jca.65822. https://pubmed.ncbi.nlm.nih.gov/35711843/

4. Huang, Jian, Liu, Wang, Zhang, Da, Lin, Biyun, Li, Benyi. 2022. TMEM158 expression is negatively regulated by AR signaling and associated with favorite survival outcomes in prostate cancers. In Frontiers in oncology, 12, 1023455. doi:10.3389/fonc.2022.1023455. https://pubmed.ncbi.nlm.nih.gov/36387246/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest